- 米国企業
- ReShape Lifesciences Inc.
ReShape Lifesciences Inc.RSLS
時価総額
$277万
PER
| 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
| Revenue | 3 | 10 | 9 | 3 | 2 | 14 | 11 |
| Cost of revenue | - | - | - | - | 1 | 5 | 4 |
| Gross profit | 1 | 5 | 4 | 0 | 1 | 8 | 7 |
| Sales and marketing | 10 | 29 | 30 | 17 | 9 | 9 | 14 |
| General and administrative | - | - | - | - | - | 24 | 17 |
| Research and development | 10 | 11 | 11 | 7 | 2 | 3 | 3 |
| Goodwill and Intangible Asset Impairment | - | - | - | - | - | - | 19 |
| Loss on disposal of assets, net | -0 | - | -0 | -0 | - | - | -1 |
| Total operating expenses | 20 | 39 | 41 | 24 | 13 | 65 | 53 |
| Operating loss | -20 | -34 | -37 | -23 | -12 | -57 | -46 |
| Interest expense, net | -0 | -0 | -0 | -0 | 0 | -1 | -0 |
| Warrant expense | - | - | - | - | - | 3 | - |
| Loss on extinguishment of debt, net | - | - | - | - | - | -2 | - |
| Loss (Gain) on foreign currency exchange, net | - | - | - | - | - | 0 | -0 |
| Other | -0 | -0 | -0 | -0 | -0 | - | 0 |
| Loss before income tax provision | - | - | - | - | - | -62 | -47 |
| Income tax benefit | - | - | - | - | - | -0 | -0 |
| Net loss | - | - | - | - | - | -62 | -46 |
| Earnings Per Share, Basic | - | - | - | - | - | -5 | -108.9 |
| Earnings Per Share, Diluted | - | - | - | - | - | -5 | -108.9 |